

Author: Schachter Michael
Publisher: Springer Publishing Company
ISSN: 0920-3206
Source: Cardiovascular Drugs and Therapy, Vol.19, Iss.6, 2005-12, pp. : 415-422
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


By Tani Shigemasa Nagao Ken Hirayama Atsushi
American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. :


High-Density Lipoprotein-Raising Strategies: Update 2010
Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. :


Should We Take High-Density Lipoprotein Cholesterol Levels at Face Value?
American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. :

